Operating Expenses

Restructuring Charges

Pfizer Restructuring Charges decreased by 92.8% to $10.00M in Q1 2024 compared to the prior quarter. Year-over-year, this metric grew by 122.7%, from -$44.00M to $10.00M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

Frequent or large charges may indicate operational instability or a need for significant strategic pivots, while occasional charges are standard in large-scale transformations.

Detailed definition

Restructuring charges are one-time costs associated with reorganizing a company's operations, such as severance pay, fac...

Peer comparison

Used by analysts to identify non-recurring items that distort year-over-year operating comparisons.

Metric ID: is_restructuring_charges

Historical Data

8 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q1 '24
Value-$5.00M$643.00M$43.00M$147.00M$177.00M-$44.00M$138.00M$10.00M
QoQ Change>999%-93.3%+241.9%+20.4%-124.9%+413.6%-92.8%
YoY Change>999%-72.5%-202.3%-6.1%+122.7%
Range-$44.00M$643.00M
CAGR+48.6%
Avg YoY Growth+576.4%
Median YoY Growth-6.1%

Business Segments

View all
SegmentQ2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q1 '25Q1 '26
Biopharma$50.00M$62.00M$246.00M-$28.00M$4.00M$1.00M$617.00M$47.00M
Total$147.00M$177.00M-$44.00M$138.00M

Restructuring Charges at Other Companies

Frequently Asked Questions

What is Pfizer's restructuring charges?
Pfizer (PFE) reported restructuring charges of $10.00M in Q1 2024.
How has Pfizer's restructuring charges changed year-over-year?
Pfizer's restructuring charges increased by 122.7% year-over-year, from -$44.00M to $10.00M.
What does restructuring charges mean?
One-time costs related to reorganizing or downsizing business operations.